Sarepta (SPRT) volatility elevated into announcing FDA requesting more data up into FDA review of eteplirsen
Go back to Sarepta (SPRT) volatility elevated into announcing FDA requesting more data up into FDA review of eteplirsen| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 19.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.79 | 52 Week High | $63.73 | |||
| Open | $19.79 | 52 Week Low | $8.00 | |||
| Day High | $19.79 | P/E | N/A | |||
| Day Low | $19.79 | EPS | $-5.69 | |||
| Volume | 3,944 | |||||
